A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy

Clinical trial NCT05414175 · COMPLETED

Trial details

NCT number: NCT05414175
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiomyopathy, Hypertrophic Obstructive

Start date: 2022-08-19
Primary completion: 2023-11-27
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.